Mode
Text Size
Log in / Sign up

Narrative review explores aged epicardial adipose tissue as a target for mitigating age-related coronary artery calcification in the elderly.

Narrative review explores aged epicardial adipose tissue as a target for mitigating age-related coro…
Photo by FlyD / Unsplash
Key Takeaway
Consider targeting the metabolic-endocrine network as a promising, though not yet quantified, avenue for mitigating age-related coronary artery calcification.

This narrative review focuses on the relationship between aged epicardial adipose tissue (EAT) and conditions such as coronary artery calcification and vascular aging. The scope of the discussion centers on the elderly population, though the specific setting and sample size were not reported. The authors do not provide data on interventions, comparators, or primary outcomes, as these details are absent from the provided evidence.

The main synthesized argument presented is that targeting the metabolic-endocrine network offers a promising strategic avenue for mitigating age-related coronary artery calcification. This conclusion is drawn qualitatively, as no pooled effect sizes, p-values, or confidence intervals are available to quantify the magnitude of this association. The review does not report specific adverse events, tolerability, or discontinuations, nor does it establish a specific follow-up duration.

Limitations acknowledged by the authors or inherent to the source include the lack of reported safety data and the absence of specific trial-level metrics. Because the evidence is a narrative review without reported causality notes or certainty ratings, the findings should be interpreted as exploratory rather than definitive. The practice relevance is framed cautiously, noting the potential strategic value of the metabolic-endocrine network without overstating the current level of clinical certainty.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Coronary artery calcification (CAC) is a hallmark of vascular aging and a major contributor to cardiovascular morbidity in the elderly. Recent evidence has identified epicardial adipose tissue (EAT) as a metabolically active endocrine organ whose age-related dysfunction critically contributes to this process. During aging, EAT undergoes a profound phenotypic switch—from a protective metabolic reservoir to a pathogenic secretory neighbor—that actively drives CAC progression. This review synthesizes current evidence to propose a novel conceptual framework: aged EAT orchestrates a multi-tiered and interactive metabolic-endocrine network that accelerates vascular calcification. At the core of this network lies a mutually reinforcing axis of chronic inflammation and oxidative stress, both fueled by underlying metabolic dysregulation. Built upon this foundation, dysregulated autophagy and apoptosis govern cellular fate decisions, while pathological vascular remodeling reshapes the extracellular matrix. Superimposed on these layers, a spectrum of dysregulated microRNAs acts as a master regulatory tier, integrating metabolic, inflammatory, and oxidative signals to amplify the entire network. By deciphering the complex crosstalk within this system, we identify key nodes where metabolic and endocrine signals converge—positioning the aged EAT as both a sensor and driver of vascular pathology. We conclude that targeting this metabolic-endocrine network offers a promising strategic avenue for mitigating age-related CAC, opening new frontiers for therapeutic intervention.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.